Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2025-12-25 @ 12:36 AM
NCT ID:
NCT00548067
Eligibility Criteria:
Inclusion Criteria:
\- Patients diagnosed as hypertensive
* Untreated confirmed hypertensive patients (consistent SBP \>140 mm Hg or DBP \>90 mm Hg)
* Uncontrolled hypertensive patients (Consistent SBP \>140 mm Hg or DBP \>90 mm Hg) on one drug therapy.
* Uncontrolled hypertensive patients (Consistent SBP \>140 mm Hg or DBP \>90 mm Hg) on two drug therapy.
Exclusion Criteria:
* Inability to switch from all prior antihypertensive medications safely as required by the protocol.
* Need for drugs other than study drugs at the time of baseline.
* Patients with SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg at screening.
* Patients on four or more antihypertensive drugs at screening.
* Pregnant or nursing (lactating) women.
* Patients with diabetes mellitus
* Patients with heart diseases and any other disease
Other protocol-defined inclusion/exclusion criteria may apply
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00548067
Study Brief:
Protocol Section:
NCT00548067